Third-line treatment in metastatic renal cell carcinoma and bone metastases

by Heng, Daniel Y. C.
Published in Can Urol Assoc J (2015)

The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma

by Heng, Daniel Y.C.
Published in Can Urol Assoc J (2016)

Contemporary Treatment of Metastatic Renal Cell Carcinoma

by Stukalin, Igor, Alimohamed, Nimira, Heng, Daniel Y.C.
Published in Oncol Rev (2016)

Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

by Ruiz-Morales, Jose Manuel, Heng, Daniel Y.C.
Published in Ther Adv Urol (2016)

Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions

by Heng, Daniel Y.C., Kollmannsberger, Christian, Chi, Kim N.
Published 2010

Impact of Body Composition on Clinical Outcomes in Metastatic Renal Cell Cancer

by Tang, Patricia A., Heng, Daniel Y. C., Choueiri, Toni K.
Published 2011

Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies

by Yip, Steven M., Heng, Daniel Y.C., Tang, Patricia A.
Published in J Kidney Cancer VHL (2016)

Personalized Management of Advanced Kidney Cancer

by Graham, Jeffrey, Heng, Daniel Y. C., Brugarolas, James, Vaishampayan, Ulka
Published in Am Soc Clin Oncol Educ Book (2018)

In Reply

by de Velasco, Guillermo, Culhane, Aedín C., Heng, Daniel Y.C., Signoretti, Sabina, Choueiri, Toni K.
Published in Oncologist (2017)

Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres

by Ko, Jenny J., Asif, Tehmina, Li, Haocheng, Alimohamed, Nimira, Nguyen, Phuong Thao, Heng, Daniel Y.C.
Published in Can Urol Assoc J (2016)

Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma

by McKay, Rana R., Lin, Xun, Perkins, Julia J., Heng, Daniel Y. C., Simantov, Ronit, Choueiri, Toni K.
Published 2014

Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma

by Lalani, Aly-Khan A., Bakouny, Ziad, Farah, Subrina, Donskov, Frede, Dudani, Shaan, Heng, Daniel Y. C., Choueiri, Toni K.
Published in JAMA Oncol (2021)

A Randomized Phase II Study of AGS‐16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma

by Kollmannsberger, Christian, Choueiri, Toni K., Heng, Daniel Y.C., George, Saby, Jie, Fei, Croitoru, Ruslan, Poondru, Srinivasu, Thompson, John A.
Published in Oncologist (2021)

Renal cell carcinoma

by Hsieh, James J., Purdue, Mark P., Signoretti, Sabina, Swanton, Charles, Albiges, Laurence, Schmidinger, Manuela, Heng, Daniel Y., Larkin, James, Ficarra, Vincenzo
Published in Nat Rev Dis Primers (2017)

Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies

by Heng, Daniel Y., Signorovitch, James, Swallow, Elyse, Li, Nanxin, Zhong, Yichen, Qin, Paige, Zhuo, Daisy Y., Wang, Xufang, Park, Jinhee, Stergiopoulos, Sotirios, Kollmannsberger, Christian
Published in PLoS One (2014)

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer

by Clayton, Ravinder, Wu, Jackson, Heng, Daniel Y., North, Scott A., Emmenegger, Urban, Hotte, Sebastien, Chi, Kim, Zielinski, Rob, Al-Shamsi, Humaid, Chen, Leo, Eigl, Bernhard
Published 2014

Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial

by Ristau, Benjamin T., Manola, Judi, Haas, Naomi B., Heng, Daniel Y. C., Messing, Edward M., Wood, Christopher G., Kane, Christopher J., DiPaola, Robert S., Uzzo, Robert G.
Published in J Urol (2017)

Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

by Sander, Michael S., Stukalin, Igor, Vallerand, Isabelle A., Goutam, Siddhartha, Ewanchuk, Benjamin W., Meyers, Daniel E., Pabani, Aliyah, Morris, Don G., Heng, Daniel Y. C., Cheng, Tina
Published in Cancer Med (2021)

Progression-Free Survival as a Predictor of Overall Survival in Metastatic Renal Cell Carcinoma Treated With Contemporary Targeted Therapy

by Heng, Daniel Y. C., Xie, Wanling, Bjarnason, Georg A., Vaishampayan, Ulka, Tan, Min-Han, Knox, Jennifer, Donskov, Frede, Wood, Lori, Kollmannsberger, Christian, Rini, Brian I., Choueiri, Toni K.
Published 2010

Vascular endothelial growth factor (VEGF)-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

by Choueiri, Toni K., Lim, Zita Dubauskas, Hirsch, Michelle S., Tamboli, Pheroze, Jonasch, Eric, McDermott, David F., Cin, Paola Dal, Corn, Paul, Vaishampayan, Ulka, Heng, Daniel Y.C., Tannir, Nizar M.
Published in Cancer (2010)